KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Tenet Healthcare (THC) EBITDA (2016 - 2025)

Tenet Healthcare's EBITDA history spans 17 years, with the latest figure at $853.0 million for Q4 2025.

  • For Q4 2025, EBITDA rose 3.9% year-over-year to $853.0 million; the TTM value through Dec 2025 reached $3.5 billion, down 41.1%, while the annual FY2025 figure was $4.2 billion, 36.31% down from the prior year.
  • EBITDA for Q4 2025 was $853.0 million at Tenet Healthcare, down from $889.0 million in the prior quarter.
  • Across five years, EBITDA topped out at $3.3 billion in Q1 2024 and bottomed at $520.0 million in Q1 2021.
  • The 5-year median for EBITDA is $743.0 million (2021), against an average of $858.9 million.
  • The largest annual shift saw EBITDA skyrocketed 444.78% in 2024 before it tumbled 71.29% in 2025.
  • A 5-year view of EBITDA shows it stood at $751.0 million in 2021, then decreased by 28.63% to $536.0 million in 2022, then surged by 37.13% to $735.0 million in 2023, then rose by 11.7% to $821.0 million in 2024, then increased by 3.9% to $853.0 million in 2025.
  • Per Business Quant, the three most recent readings for THC's EBITDA are $853.0 million (Q4 2025), $889.0 million (Q3 2025), and $823.0 million (Q2 2025).